Literature DB >> 26049728

Osteochondromas in fibrodysplasia ossificans progressiva: a widespread trait with a streaking but overlooked appearance when arising at femoral bone end.

A Morales-Piga1,2, J Bachiller-Corral3, P González-Herranz4, M Medrano-SanIldelfonso5, J Olmedo-Garzón6, G Sánchez-Duffhues7.   

Abstract

Metaphyseal bony outgrowths are a well-recognized feature of fibrodysplasia ossificans progressiva (FOP) phenotype, but its genuine frequency, topographic distribution, morphological aspect, and potential implications are not fully established. To better ascertain the frequency and characteristics of osteocartilaginous exostoses in FOP disease, we conducted a cross-sectional radiological study based on all the traceable cases identified in a previous comprehensive national research. Metaphyseal exostoses were present in all the 17 cases of FOP studied. Although most often arising from the distal femoral (where metaphyseal exostoses adopt a peculiar not yet reported appearance) and proximal tibial bones, we have found that they are not restricted to these areas, but rather can be seen scattered at a variety of other skeletal sites. Using nuclear magnetic resonance imaging, we show that these exophytic outgrowths are true osteochondromas. As a whole, these results are in agreement with data coming from the literature review. Our study confirms the presence of metaphyseal osteochondromas as a very frequent trait of FOP phenotype and an outstanding feature of its anomalous skeletal developmental component. In line with recent evidences, this might imply that dysregulation of BMP signaling, in addition to promoting exuberant heterotopic ossification, could induce aberrant chondrogenesis and osteochondroma formation. Unveiling the molecular links between these physiopathological pathways could help to illuminate the mechanisms that govern bone morphogenesis.

Entities:  

Keywords:  Chondrogenesis; Exostoses; FOP; Fibrodysplasia ossificans progressiva; Osteochondroma

Mesh:

Year:  2015        PMID: 26049728     DOI: 10.1007/s00296-015-3301-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

1.  Failure of surgery and isotretinoin to relieve jaw immobilization in fibrodysplasia ossificans progressiva: report of two cases.

Authors:  L J Crofford; J S Brahim; M A Zasloff; J C Marini
Journal:  J Oral Maxillofac Surg       Date:  1990-02       Impact factor: 1.895

2.  A CONTRIBUTION TO THE STUDY OF MYOSITIS OSSIFICANS PROGRESSIVA.

Authors:  J Rosenstirn
Journal:  Ann Surg       Date:  1918-11       Impact factor: 12.969

Review 3.  The control of chondrogenesis.

Authors:  Mary B Goldring; Kaneyuki Tsuchimochi; Kosei Ijiri
Journal:  J Cell Biochem       Date:  2006-01-01       Impact factor: 4.429

4.  A three generation family with fibrodysplasia ossificans progressiva.

Authors:  J M Connor; H Skirton; P W Lunt
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

5.  The hand and foot malformations in fibrodysplasia ossificans progressiva.

Authors:  H W Schroeder; M Zasloff
Journal:  Johns Hopkins Med J       Date:  1980-08

6.  Fibrodysplasia ossificans progressiva and associated osteochondroma of the coronoid process in a child.

Authors:  V Chichareon; P Arpornmaeklong; N Donsakul
Journal:  Plast Reconstr Surg       Date:  1999-04       Impact factor: 4.730

7.  Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo.

Authors:  Byeong S Yoon; Dmitry A Ovchinnikov; Isaac Yoshii; Yuji Mishina; Richard R Behringer; Karen M Lyons
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

8.  Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients.

Authors:  J M Connor; D A Evans
Journal:  J Bone Joint Surg Br       Date:  1982

9.  ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development.

Authors:  Donghui Zhang; Edward M Schwarz; Randy N Rosier; Michael J Zuscik; J Edward Puzas; Regis J O'Keefe
Journal:  J Bone Miner Res       Date:  2003-09       Impact factor: 6.741

Review 10.  Fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Martine Le Merrer; David L Glaser; Robert J Pignolo; Robert E Goldsby; Joseph A Kitterman; Jay Groppe; Eileen M Shore
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

View more
  8 in total

1.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

2.  A Case of Fibrodysplasia Ossificans Progressiva in a 5-year-old Boy with all Musculoskeletal Features and Review of the Literature.

Authors:  Melih Civan; Fuat Bilgili; Ayse Kilic; ZeyraOya Uyguner; Guven Toksoy
Journal:  J Orthop Case Rep       Date:  2018 Sep-Oct

Review 3.  Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.

Authors:  Frederick S Kaplan; Mona Al Mukaddam; Alexandra Stanley; O Will Towler; Eileen M Shore
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

4.  Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: Case report.

Authors:  Zhankui Wang; Xiuhua Wang; Baojin Liu; Yanfeng Hou
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

5.  Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP).

Authors:  O Will Towler; Sun H Peck; Frederick S Kaplan; Eileen M Shore
Journal:  Dev Biol       Date:  2020-11-17       Impact factor: 3.582

Review 6.  BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).

Authors:  Oscar Will Towler; Eileen M Shore
Journal:  Dev Dyn       Date:  2021-06-26       Impact factor: 2.842

7.  Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity.

Authors:  John B Lees-Shepard; Sarah-Anne E Nicholas; Sean J Stoessel; Parvathi M Devarakonda; Michael J Schneider; Masakazu Yamamoto; David J Goldhamer
Journal:  Elife       Date:  2018-09-18       Impact factor: 8.140

Review 8.  Bone morphogenetic protein receptor signal transduction in human disease.

Authors:  Maria Catalina Gomez-Puerto; Prasanna Vasudevan Iyengar; Amaya García de Vinuesa; Peter Ten Dijke; Gonzalo Sanchez-Duffhues
Journal:  J Pathol       Date:  2018-11-27       Impact factor: 7.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.